Spotlight -

Downstream Processing|

Upstream Processing

Biopharma Insights-Thought Leadership from Marketers | Sponsored Content | CEVEC

EP. 1: Reduction of Product-related Impurities during Production of recombinant Adeno-Associated Viruses

ByDr. Michelle Hussong, Head of Molecular Biology - Technology and Assay Development, CEVEC Pharmaceuticals GmbH,Dr. Tobias Bonifert, Head of Vector Technology, CEVEC Pharmaceuticals GmbH,Prof. Dr. Nico Scheer, Senior Consultant Business Development, CEVEC Pharmaceuticals GmbH, Professor in Molecular Biology at FH Aachen, University of Applied Sciences, Germany

June 9th 2022

EP. 2: ELEVECTA® - The Next Level in Gene Therapy AAV Production

ByPetra Nitschke, Biopharma Insights Contributor, Business Development CEVEC Pharmaceuticals GmbH

August 10th 2020

Introduction of ELEVECTA®, CEVEC’s fully scalable and stable production platform for AAV gene therapy viral vector manufacturing.

Trending on BioPharm International

Rentschler’s Time Capsule and How it Symbolizes European Biotech Progress

Analytics, Automation, and Quality Driving the Next Era of Drug Development

Therapeutic Nucleic Acids: Advanced Solutions for Downstream Processing & Analysis

New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes

© 2025 MJH Life Sciences^®

All rights reserved.